MAGEA3 and melanoma: Examples of cancer peptide vaccines that have been studied in phase III trials include the MAGE-A3 cancer testis antigen for non-small cell squamous lung cancer/melanoma, rindopepimut for glioblastoma (GBM), and sipuleucel-T for prostate cancer [5, 7, 48, 51].